Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Rituximab Maintenance Treatment for a Maximum of 5 Years in Follicular Lymphoma: Final Results of the Randomized Phase III Trial SAKK 35/03

Christian Taverna, MD, Giovanni Martinelli, MD, Felicitas Hitz, MD, Walter Mingrone, MD, Thomas Pabst, MD PhD, Lidija Cevreska, MD PhD, Auro del Giglio, MD, Anna Vanazzi, MD, Daniele Laszlo, MD, Johann Raats, Daniel Rauch, Daniel Vorobiof, Andreas Lohri, MD, Emanuele Zucca, Celine Rueegsegger, Stephanie - Rondeau, Corinne Rusterholz, Michele Ghielmini

Blood (2018) 132 (Supplement 1): 1601.

https://doi.org/10.1182/blood-2018-99-116864

Published: 2018

Journal Articles

A Cellular Therapy with Haploidentical Peripheral Hematopoietic STEM CELL Transplantation MAY be a Therapeutic Option in Patients with Relapsed Lymphoma with Chemorefractory Disease

Simona Sammassimo, Daniele Avenoso, Federica Gigli, Daniele Laszlo, MD, Francesco Bertolini, MD PhD, Giammarco Russo, Corrado Tarella, MD Prof, Rocco Pastano

Blood (2018) 132 (Supplement 1): 2189.

https://doi.org/10.1182/blood-2018-99-119752

Published: 2018

Journal Articles

Clinical Outcomes of Patients with Anaplastic Large Cell Lymphoma, Anaplastic Lymphoma Kinase-Negative (ALCL, ALK-): Analysis of 203 Patients Prospectively Registered in the International T-Cell Project

Andrei Shustov, MD, Maria Elena Cabrera, Monica Bellei, MSc, PhD, Young Hyeh Ko, MD, Martina Manni, PhD, Steven M. Horwitz, MD, Carmino Antonio De Souza, MD PhD, John A. Radford, MD, Sabela Bobillo Varela, Maria Virginia Prates, MD, Andrés J M Ferreri, MD, Carlos Chiattone, MD, Michele Spina, MD, Julie M. Vose, MDMBA, Annalisa Chiappella, MD, Daniele Laszlo, MD, Dario Marino, MDPhD, Caterina Stelitano, Massimo Federico, MD

Blood (2017) 130 (Supplement 1): 4071.

https://doi.org/10.1182/blood.V130.Suppl_1.4071.4071

Published: 2017

Journal Articles

Concurrent Follicular Lymphoma At Diagnosis Has a Negative Impact On The Outcome Of Patients With Diffuse Large B Cell Lymphoma

David Wrench, MD, PhD, Hasan Rizvi, MD, Andrew Wilson, Ciaran O'Riain, MD, PhD, Andrew Clear, Janet Matthews, Daniele Laszlo, MD, T. Andrew Lister, MD, John G. Gribben, MD, DSc, FRCP, FMedSci, FRCPath, Maria Calaminici, MD, PhD, Silvia Montoto, MD

Blood (2013) 122 (21): 4260.

https://doi.org/10.1182/blood.V122.21.4260.4260

Published: 2013

Journal Articles

Rituximab and Chlorambucil as Front-Line Treatment in Untreated Follicular Lymphoma: a Combination with a Durable Response and Low Toxicity Profile.

Simona Bassi, MD, Luca Nassi, MD, Giancarlo Pruneri, MD, Simona Sammassimo, MD, Paola Bertazzoni, MD, Federica Gigli, MD, Anna Vanazzi, MD, Emilia Cocorocchio, MD, Patrizia Mancuso, Cristina Rabascio, Maria Teresa Lionetti, Daniele Laszlo, MD, Giovanni Martinelli, MD

Blood (2009) 114 (22): 3754.

https://doi.org/10.1182/blood.V114.22.3754.3754

Published: 2009

Journal Articles

90 y-Ibritumomab Tiuxetan or Purine Analogues Severely Affect Peripheral Blood Stem Cell Mobilization: An Analysis On 248 Patients.

Anna Vanazzi, MD, Alessandra Alietti, MD, Alberto Agazzi, MD, Mara Negri, Maria Teresa Lionetti, Aleksandra Babic, Davide Radice, Luca Nassi, MD, Simona Sammassimo, MD, Cristina Rabascio, Pierluigi Antoniotti, Lara Roveda, Bruno Lucchetti, Tiziana Suardi, Alessio Piredda, Liliana Calabrese, Giovanni Martinelli, MD, Daniele Laszlo, MD

Blood (2009) 114 (22): 3210.

https://doi.org/10.1182/blood.V114.22.3210.3210

Published: 2009

Journal Articles

Continuous Immuno-Chemotherapy Followed by High Dose and Autologous Cell Transplantation May Improve the Event-Free-Survival in Mantle Cell Lymphoma Patients. Experience at the European Institute of Oncology in Milan.

Simona Bassi, MD, Alessandra Alietti, MD, Chiara Corsini, DSc, Federica Gigli, MD, Paola Bertazzoni, MD, Cristina Rabascio, DSc, Patrizia Mancuso, DSc, Emilia Cocorocchio, MD, Daniele Laszlo, MD, Giancarlo Pruneri, MD, Lorenzo Preda, MD, Sarah J. Liptrott, BN, Rosaria Cascio, PH, Francesco Bertolini, MD, Giovanni Martinelli, MD

Blood (2007) 110 (11): 5116.

https://doi.org/10.1182/blood.V110.11.5116.5116

Published: 2007

Journal Articles

Expression of the Human Concentrative Nucleotide Transporter (hCNT1) Gene Correlates with Clinical Response in Patients Affected by Waldenstrom’s Macroglobulinemia (WM), Undergoing a Combination Treatment with Cladribine (2-CdA) and Rituximab.

Daniele Laszlo, MD, Cristina Rabascio, DSc, Giovanna Andreola, MD, Luca Saronni, DSc, Liliana Calabrese, DSc, Luigi Rigacci, MD, Alberto Fabbri, MD, Antonello Pinto, MD, Ferdinando Frigeri, MD, Atto Billio, MD, Graziella Pinotti, MD, Simona Sammassimo, MD, Giovanni Martinelli, MD

Blood (2007) 110 (11): 1357.

https://doi.org/10.1182/blood.V110.11.1357.1357

Published: 2007

Journal Articles

Tissue Microarray (TMA) Study in DLBC Lymphomas (DLBCL): Could the Extranodal Origin Affect the Prognostic Impact of the Analysis?.

Daniele Laszlo, MD, Giancarlo Pruneri, MD, Giovanna Andreola, MD, Davide Radice, ST, Liliana Calabrese, DM, Alessandra Alietti, MD, Alberto Agazzi, MD, Anna Vanazzi, MD, Giovanni Martinelli, MD

Blood (2006) 108 (11): 2037.

https://doi.org/10.1182/blood.V108.11.2037.2037

Published: 2006

Journal Articles

Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation in Renal Cell Carcinoma: The EIO Experience.

Rocco Pastano, MD, Daniele Laszlo, MD, Giovanna Andreola, MD, Federica Gigli, MD, Cristina Rabascio, Valentina Raia, Manuela Cazzanti, Fedro Peccatori, MD, Giovanni Martinelli, MD

Blood (2005) 106 (11): 5424.

https://doi.org/10.1182/blood.V106.11.5424.5424

Published: 2005

NARROW

Rituximab Maintenance Treatment for a Maximum of 5 Years in Follicular Lymphoma: Final Results of the Randomized Phase III Trial SAKK 35/03

A Cellular Therapy with Haploidentical Peripheral Hematopoietic STEM CELL Transplantation MAY be a Therapeutic Option in Patients with Relapsed Lymphoma with Chemorefractory Disease

Clinical Outcomes of Patients with Anaplastic Large Cell Lymphoma, Anaplastic Lymphoma Kinase-Negative (ALCL, ALK-): Analysis of 203 Patients Prospectively Registered in the International T-Cell Project

Concurrent Follicular Lymphoma At Diagnosis Has a Negative Impact On The Outcome Of Patients With Diffuse Large B Cell Lymphoma

Rituximab and Chlorambucil as Front-Line Treatment in Untreated Follicular Lymphoma: a Combination with a Durable Response and Low Toxicity Profile.

90 y-Ibritumomab Tiuxetan or Purine Analogues Severely Affect Peripheral Blood Stem Cell Mobilization: An Analysis On 248 Patients.

Continuous Immuno-Chemotherapy Followed by High Dose and Autologous Cell Transplantation May Improve the Event-Free-Survival in Mantle Cell Lymphoma Patients. Experience at the European Institute of Oncology in Milan.

Expression of the Human Concentrative Nucleotide Transporter (hCNT1) Gene Correlates with Clinical Response in Patients Affected by Waldenstrom’s Macroglobulinemia (WM), Undergoing a Combination Treatment with Cladribine (2-CdA) and Rituximab.

Tissue Microarray (TMA) Study in DLBC Lymphomas (DLBCL): Could the Extranodal Origin Affect the Prognostic Impact of the Analysis?.

Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation in Renal Cell Carcinoma: The EIO Experience.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only